EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review

Giulia Bononi iD, Chiara Lonzi, Tiziano Tuccinardi iD, Filippo Minutolo iD, Carlotta Granchi iD

Molecules · 2024

DOI: 10.3390/molecules29091930 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Giulia Bononi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Piperidines, Chemistry, Pharmaceutical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Italian Ministry of Health—Ricerca Finalizzata 2016.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The phenyl(piperidin-4-yl)methanone fragment (here referred to as the benzoylpiperidine fragment) is a privileged structure in the development of new drugs considering its presence in many bioactive small molecules with both therapeutic (such as anti-cancer, anti-psychotic, anti-thrombotic, anti-arrhythmic, anti-tubercular, anti-parasitic, anti-diabetic, and neuroprotective agents) and diagnostic properties. The benzoylpiperidine fragment is metabolically stable, and it is also considered a potential bioisostere of the piperazine ring, thus making it a feasible and reliable chemical frame to be exploited in drug design. Herein, we discuss the main therapeutic and diagnostic agents presenting the benzoylpiperidine motif in their structure, covering articles reported in the literature since 2000. A specific section is focused on the synthetic strategies adopted to obtain this versatile chemical portion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesChemistry, PharmaceuticalHumansDrug DesignMolecular StructureAntineoplastic AgentsStructure-Activity RelationshipNeuroprotective Agents

Stichwörter der Autor:innen

benzoylpiperidinebenzoylpiperidine-based small moleculesbioisosterediagnostic agentsdrug designmedicinal chemistryphenyl(piperidin-4-yl)methanoneprivileged structuretherapeutic agents

Substanzen

PiperidinesAntineoplastic AgentsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.

ORCID-Profile: Giulia Bononi, Tiziano Tuccinardi, Filippo Minutolo, Carlotta Granchi

Förderung

  • Italian Ministry of Health
  • Italian Ministry of Health—Ricerca Finalizzata 2016

Zitieren

APA

Bononi, G., Lonzi, C., Tuccinardi, T., Minutolo, F., & Granchi, C. (2024). The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review. Molecules. https://doi.org/10.3390/molecules29091930

Vancouver

Bononi G, Lonzi C, Tuccinardi T, Minutolo F, Granchi C. The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review. Molecules. 2024. doi:10.3390/molecules29091930

BibTeX
@article{Bononi2024,
  author = {Bononi, Giulia and Lonzi, Chiara and Tuccinardi, Tiziano and Minutolo, Filippo and Granchi, Carlotta},
  title = {The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29091930}
}
Kostenlos starten →